[1]
T. Dajsakdipon, J. Konmun, U. Udomsubpayakul, and T. Dejthevaporn, “Real World Experience of Long Term Treatment Outcome in Hormone Receptor-positive Metastatic Breast Cancer with or without Everolimus and Exemestane after Prior Aromatase Inhibitor”, Asian Pac J Cancer Care, vol. 6, no. 2, pp. 149–158, May 2021.